Loss of Col3a1, the Gene for Ehlers-Danlos Syndrome Type IV, Results in Neocortical Dyslamination

Hdl Handle:
http://hdl.handle.net/10675.2/692
Title:
Loss of Col3a1, the Gene for Ehlers-Danlos Syndrome Type IV, Results in Neocortical Dyslamination
Authors:
Jeong, Sung-Jin; Li, Shihong; Luo, Rong; Strokes, Natalie; Piao, Xianhua
Abstract:
It has recently been discovered that Collagen III, the encoded protein of the type IV Ehlers-Danlos Syndrome (EDS) gene, is one of the major constituents of the pial basement membrane (BM) and serves as the ligand for GPR56. Mutations in GPR56 cause a severe human brain malformation called bilateral frontoparietal polymicrogyria, in which neurons transmigrate through the BM causing severe mental retardation and frequent seizures. To further characterize the brain phenotype of Col3a1 knockout mice, we performed a detailed histological analysis. We observed a cobblestone-like cortical malformation, with BM breakdown and marginal zone heterotopias in Col3a1-/- mouse brains. Surprisingly, the pial BM appeared intact at early stages of development but starting as early as embryonic day (E) 11.5, prominent BM defects were observed and accompanied by neuronal overmigration. Although collagen III is expressed in meningeal fibroblasts (MFs), Col3a1-/- MFs present no obvious defects. Furthermore, the expression and posttranslational modification of a-dystroglycan was undisturbed in Col3a1-/- mice. Based on the previous finding that mutations in COL3A1 cause type IV EDS, our study indicates a possible common pathological pathway linking connective tissue diseases and brain malformations.
Editors:
Mei, Lin
Citation:
PLoS One. 2012 Jan 3; 7(1):e29767
Issue Date:
3-Jan-2012
URI:
http://hdl.handle.net/10675.2/692
DOI:
10.1371/journal.pone.0029767
PubMed ID:
22235340
PubMed Central ID:
PMC3250483
Type:
Article
ISSN:
1932-6203
Appears in Collections:
Department of Neurology: Faculty Research and Presentations

Full metadata record

DC FieldValue Language
dc.contributor.authorJeong, Sung-Jinen_US
dc.contributor.authorLi, Shihongen_US
dc.contributor.authorLuo, Rongen_US
dc.contributor.authorStrokes, Natalieen_US
dc.contributor.authorPiao, Xianhuaen_US
dc.contributor.editorMei, Lin-
dc.date.accessioned2012-10-26T16:29:35Z-
dc.date.available2012-10-26T16:29:35Z-
dc.date.issued2012-01-3en_US
dc.identifier.citationPLoS One. 2012 Jan 3; 7(1):e29767en_US
dc.identifier.issn1932-6203en_US
dc.identifier.pmid22235340en_US
dc.identifier.doi10.1371/journal.pone.0029767en_US
dc.identifier.urihttp://hdl.handle.net/10675.2/692-
dc.description.abstractIt has recently been discovered that Collagen III, the encoded protein of the type IV Ehlers-Danlos Syndrome (EDS) gene, is one of the major constituents of the pial basement membrane (BM) and serves as the ligand for GPR56. Mutations in GPR56 cause a severe human brain malformation called bilateral frontoparietal polymicrogyria, in which neurons transmigrate through the BM causing severe mental retardation and frequent seizures. To further characterize the brain phenotype of Col3a1 knockout mice, we performed a detailed histological analysis. We observed a cobblestone-like cortical malformation, with BM breakdown and marginal zone heterotopias in Col3a1-/- mouse brains. Surprisingly, the pial BM appeared intact at early stages of development but starting as early as embryonic day (E) 11.5, prominent BM defects were observed and accompanied by neuronal overmigration. Although collagen III is expressed in meningeal fibroblasts (MFs), Col3a1-/- MFs present no obvious defects. Furthermore, the expression and posttranslational modification of a-dystroglycan was undisturbed in Col3a1-/- mice. Based on the previous finding that mutations in COL3A1 cause type IV EDS, our study indicates a possible common pathological pathway linking connective tissue diseases and brain malformations.en_US
dc.rightsJeong et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_US
dc.subjectResearch Articleen_US
dc.subjectBiologyen_US
dc.subjectBiochemistryen_US
dc.subjectCytochemistryen_US
dc.subjectExtracellular Matrixen_US
dc.subjectProteinsen_US
dc.subjectMolecular Cell Biologyen_US
dc.subjectCellular Typesen_US
dc.subjectExtracellular Matrixen_US
dc.subjectNeuroscienceen_US
dc.subjectMedicineen_US
dc.subjectAnatomy and Physiologyen_US
dc.subjectNeurological Systemen_US
dc.subjectNeurologyen_US
dc.subject.meshAnimalsen_US
dc.subject.meshBasement Membraneen_US
dc.subject.meshCollagen Type IIIen_US
dc.subject.meshEhlers-Danlos Syndromeen_US
dc.subject.meshGene Deletionen_US
dc.subject.meshHumansen_US
dc.subject.meshInterneuronsen_US
dc.subject.meshMiceen_US
dc.subject.meshNeocortexen_US
dc.subject.meshNeurogliaen_US
dc.titleLoss of Col3a1, the Gene for Ehlers-Danlos Syndrome Type IV, Results in Neocortical Dyslaminationen_US
dc.typeArticleen_US
dc.identifier.pmcidPMC3250483en_US
dc.contributor.corporatenameDepartment of Neurology-
dc.contributor.corporatenameCollege of Graduate Studies-

Related articles on PubMed

All Items in Scholarly Commons are protected by copyright, with all rights reserved, unless otherwise indicated.